The clinical significance of IgA antiphospholipid antibodies: Editorial

Journal of Rheumatology

Volumn 28, Issue 4, 2001, Pages 694-697

  Samarkos, M ^a   Asherson, R A ^a   Loizou, S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; EDITORIAL; FETUS WASTAGE; HEMOLYTIC ANEMIA; HUMAN; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOGENICITY; THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; HUMANS; IMMUNOGLOBULIN A; PHOSPHOLIPIDS;

EID: 0035088286     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (42)

1. Immunology and clinical importance of antiphospholipid antibodies
2. Anticardiolipin antibodies, chronic biologic false-positive tests for syphilis and other antiphospholipid antibodies
3. Clinical and serological features of the "antiphospholipid syndrome"
4. Immunology of the antiphospholipid syndrome
5. 2-glycoprotein-I than With antiphospholipid antibodies
6. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
7. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus
8. 2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus
9. 2-glycoprotein I antibodies in patients with IgA monoclonal gammopathy
10. Requirement of ß2 glycoprotein I as cofactor in the binding for IgM and IgA anticardiolipin antibodies
11. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome
12. IgA class anti-ß2-glycoprotein I in patients with systemic lupus erythematosus
13. 2-glycoprotein I antibodies: Importance of IgA isotype
14. Significance of IgA antiphospholipid antibodies
15. Mucosal versus non-mucosal IgA aCL and anti-ß2-GPI
16. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity
17. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders
18. IgA anticardiolipin antibodies - Relation with other antiphospholipid antibodies and clinical significance
19. HLA class II alleles associations of anticardiolipin and anti-ß2-GPI antibodies in a large series of European patients with systemic lupus erythematosus
20. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus
21. Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus
22. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus
23. Clinical significance of immunoglobulin A antiphospholipid antibodies: Possible association with skin manifestations and small vessel vasculitis
24. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion
25. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus
26. High frequency of abnormal levels of IgA anti-ß2-glycoprotein I antibodies in patients with systemic lupus erythematosus: Relationship with antiphospholipid syndrome
27. Testing for the antiphospholipid syndrome: Importance of IgA anti-ß2-glycoprotein I
28. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus
29. Antibodies to phospholipids and nuclear antigens in non-pregnant women with unexplained spontaneous recurrent abortions
30. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus
31. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases
32. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus
33. Anticardiolipin antibodies in rheumatoid arthritis
34. Antiphospholipid antibodies and HLA associations in primary Sjogren's syndrome
35. Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis
36. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis
37. Anticardiolipin antibodies in uveitis
38. Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus
39. Anticardiolipin response in acute infections
40. Severe Guillain-Barre syndrome: An association with IgA anti-cardiolipin antibody in a series of 92 patients
41. IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis
42. Antibodies to cardiolipin and ß2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis